"hiv" blog posts
Assessing the preclinical development of long-acting biodegradable implants
I’m Dr Meg Neary, a postdoctoral research associate at the Centre of Excellence for Long-acting therapeutics (CELT). My work involves pre-clinical development of long-acting antiretroviral therapy (LA ART). LA ART provides exposure to a drug over a long period of time. This means instead of taking oral tablets, the contents of which are eliminated by the body over a very short period of time, patients can take LA ART and have effective exposure to the same drug concentration for a period of weeks, months or years.
Posted on: 31 January 2023
Taking control of the HIV epidemic – How long-acting injectables can help reach ambitious targets
HIV continues to be a global public health concern with approximately 40 million people living with HIV infection in 2021 globally – the epidemic has sadly claimed millions of lives all over the world.
Posted on: 12 September 2022